MXPA02010241A - Receptor edg8, su preparacion y uso. - Google Patents

Receptor edg8, su preparacion y uso.

Info

Publication number
MXPA02010241A
MXPA02010241A MXPA02010241A MXPA02010241A MXPA02010241A MX PA02010241 A MXPA02010241 A MX PA02010241A MX PA02010241 A MXPA02010241 A MX PA02010241A MX PA02010241 A MXPA02010241 A MX PA02010241A MX PA02010241 A MXPA02010241 A MX PA02010241A
Authority
MX
Mexico
Prior art keywords
preparation
receptor
polynucleotides
edg8
edg8 receptor
Prior art date
Application number
MXPA02010241A
Other languages
English (en)
Inventor
Johann Gassenhuber
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00108858A external-priority patent/EP1149907A1/en
Priority claimed from EP00116589A external-priority patent/EP1178110A1/en
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of MXPA02010241A publication Critical patent/MXPA02010241A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)

Abstract

La presente invencion se refiere a receptores EGDS recien identificados, a polinucleotidos que codifican este receptor, a polipeptidos codificados por tales polinucleotidos, a la preparacion y al uso de tales polinucleotidos y polipeptidos.
MXPA02010241A 2000-04-26 2001-04-14 Receptor edg8, su preparacion y uso. MXPA02010241A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00108858A EP1149907A1 (en) 2000-04-26 2000-04-26 EDG8 receptor, its preparation and use
EP00116589A EP1178110A1 (en) 2000-08-01 2000-08-01 EDG8 receptor for sphingosine 1-phosphate , its preparation and use
PCT/EP2001/004283 WO2001081573A1 (en) 2000-04-26 2001-04-14 Edg8 receptor, its preparation and use

Publications (1)

Publication Number Publication Date
MXPA02010241A true MXPA02010241A (es) 2004-09-06

Family

ID=26070860

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02010241A MXPA02010241A (es) 2000-04-26 2001-04-14 Receptor edg8, su preparacion y uso.

Country Status (14)

Country Link
US (2) US20020099191A1 (es)
EP (1) EP1278850B1 (es)
JP (1) JP5139617B2 (es)
KR (1) KR100790329B1 (es)
AT (1) ATE364697T1 (es)
AU (2) AU7048901A (es)
BR (1) BR0110248A (es)
CA (1) CA2406725C (es)
DE (1) DE60128906T2 (es)
IL (2) IL152378A0 (es)
MX (1) MXPA02010241A (es)
NO (1) NO331197B1 (es)
NZ (1) NZ522215A (es)
WO (1) WO2001081573A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812335B1 (en) 1999-03-23 2004-11-02 The Regents Of The University Of California Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
IL154879A0 (en) * 2000-10-02 2003-10-31 Novo Nordisk As Factor vii glycoforms
US20040185535A1 (en) * 2003-03-21 2004-09-23 Giles Wilson Industrial-scale serum-free production of recombinant FVII in mammalian cells
US20040185534A1 (en) * 2000-10-02 2004-09-23 Knudsen Ida Molgaard Industrial-scale serum-free production of recombinant proteins in mammalian cells
CA2454427A1 (en) * 2001-07-20 2003-01-30 Haifeng Eishingdrelo A novel g protein-coupled receptor, gave8
EP1597580A2 (en) * 2002-11-13 2005-11-23 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 5 (edg5)
WO2005009469A1 (ja) * 2003-07-28 2005-02-03 Sumitomo Pharmaceuticals Co., Ltd. 新規血糖調節薬及びそのスクリーニング方法
US20090191578A1 (en) * 2004-07-27 2009-07-30 Merck & Co., Inc Canis sphingosine 1-phosphate receptor isoform 5
US8791100B2 (en) 2010-02-02 2014-07-29 Novartis Ag Aryl benzylamine compounds
WO2014139884A2 (en) 2013-03-14 2014-09-18 Galapagos Nv Molecular targets and compounds, and methods to identify the same, useful in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
AU9794598A (en) * 1997-10-10 1999-05-03 Lxr Biotechnology Inc. Methods for detecting compounds which modulate the activity of an lpa receptor
CA2340334A1 (en) * 1998-08-19 2000-03-02 Millenium Pharmaceuticals, Inc. 14274 receptor, a g-protein coupled receptor related to the edg receptor family
WO2001004139A2 (en) * 1999-07-13 2001-01-18 Smithkline Beecham Corporation Human axor29 receptor
GB9923890D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide

Also Published As

Publication number Publication date
CA2406725A1 (en) 2001-11-01
AU7048901A (en) 2001-11-07
EP1278850B1 (en) 2007-06-13
NO331197B1 (no) 2011-10-31
BR0110248A (pt) 2003-01-07
NO20025152D0 (no) 2002-10-25
AU2001270489B2 (en) 2007-03-15
US7141383B2 (en) 2006-11-28
US20030219874A1 (en) 2003-11-27
DE60128906T2 (de) 2008-02-07
ATE364697T1 (de) 2007-07-15
EP1278850A1 (en) 2003-01-29
JP5139617B2 (ja) 2013-02-06
IL152378A (en) 2010-12-30
NZ522215A (en) 2004-05-28
KR100790329B1 (ko) 2008-01-02
CA2406725C (en) 2013-01-15
NO20025152L (no) 2002-12-13
US20020099191A1 (en) 2002-07-25
DE60128906D1 (de) 2007-07-26
JP2003530882A (ja) 2003-10-21
KR20020097234A (ko) 2002-12-31
IL152378A0 (en) 2003-05-29
WO2001081573A1 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
TW200631594A (en) Toll like receptor 3 antagonists, methods and uses
WO2003004529A3 (en) Ephrin-tie receptor materials and methods
MXPA03006950A (es) Ciclobuteno-1,2-dionas 3,4-disustituidas como antagonistas de receptor de quimiocina cxc.
MXPA02010241A (es) Receptor edg8, su preparacion y uso.
MY135916A (en) Use of certain affinity nmda antagonists as antidepressants
WO2003002604A3 (en) G protein coupled receptors and dna sequences thereof
WO2003018798A3 (en) G-protein coupled receptor and dna sequences thereof
WO2002002630A3 (en) Hcn polypeptides and polynucleotides and their use in therapy
UA87122C2 (ru) Агонисты рецепторов глюкагонподобного пептида-1, их применение и способ получения
MXPA03003892A (es) Antagonistas del receptor bombesin.
WO2005046602A3 (en) Vegf receptor antagonists
MXPA03004414A (es) Natagonistas del receptor bombesin.
WO2003018066A3 (en) A murine genomic polynucleotide sequence encoding a g-protein coupled receptor and methods of use therefor
ZA200205477B (en) 5HT3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof.
SG158098A1 (en) Toll like receptor 3 antagonists, methods and uses
AP2002002401A0 (en) Histamine receptor antagonists.
WO2002030971A3 (en) Basb205 polypeptides and polynucleotides coding therefor
WO2002000851A3 (en) Helicobacter dd-heptosyltransferase
MXPA03007984A (es) Polinucleotido que codifica receptor novedoso acoplado a proteina g humana, hgprbmy27.
GB0025170D0 (en) Novel compounds
EP1576099A3 (en) Novel polynucleotides encoding the human citron kinase polypeptide, bmsnkc 0020/0021
AU2003234717A1 (en) Novel polynucleotides encoding the human citron kinase polypeptide, bmsnkc 0020/0021
MXPA03009930A (es) Antagonistas del receptor del factor liberador de corticotropina.
GB9918208D0 (en) Novel compounds
GB0025169D0 (en) Novel compounds

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration